The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia.

MLA

Himbergen, T. M., et al. “The Effect of Statin Therapy on Plasma High-Density Lipoprotein Cholesterol Levels Is Modified by Paraoxonase-1 in Patients with Familial Hypercholesterolaemia.” Journal of Internal Medicine, vol. 258, no. 5, Nov. 2005, pp. 442–49. EBSCOhost, https://doi.org/10.1111/j.1365-2796.2005.01557.x.

APA

Himbergen, T. M., van Tits, L. J. H., Voorbij, H. A. M., de Graaf, J., Stalenhoef, A. F. H., & Roest, M. (2005). The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia. Journal of Internal Medicine, 258(5), 442–449. https://doi.org/10.1111/j.1365-2796.2005.01557.x

Chicago

Himbergen, T M, L J H van Tits, H A M Voorbij, J de Graaf, A F H Stalenhoef, and M Roest. 2005. “The Effect of Statin Therapy on Plasma High-Density Lipoprotein Cholesterol Levels Is Modified by Paraoxonase-1 in Patients with Familial Hypercholesterolaemia.” Journal of Internal Medicine 258 (5): 442–49. doi:10.1111/j.1365-2796.2005.01557.x.